FTSE 100 news / Companies and sectors / Smith & Nephew / 20 October 2026

Smith & Nephew (SN): news on Tuesday 20 October 2026

−0.7 neutral

Coverage centred on Smith & Nephew's struggle against Stryker in knee replacement robotics, which weighs on the tone. A UBS note pointing to attractive risk/reward ahead of third-quarter results offset some of that.

What drove it

knee robot competition
Stryker rivalry
UBS medtech view

The 3 stories

Each headline's own score, strongest first. Links go to the publisher.

+7.0 UBS sees attractive risk/reward in three European medtech into Q3 results Investing.com
UBS sees attractive risk/reward in medtech names ahead of Q3 results.
−4.7 Smith & Nephew seeks knee robot recovery as Stryker extends orthopaedics lead Traders Union
Smith & Nephew trailing Stryker in knee robotics; needs recovery.
−0.8 The battle of the knee replacement robots FT Companies
Feature on knee robot competition; company likely named party, balanced tone.

Smith & Nephew: every day · Pharma and healthcare on 20 October 2026 · FTSE 100 overview for the day